|
ZWILCH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.406200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.143800E-01 |
| Normal-vs-Stage2 |
6.221200E-03 |
| Normal-vs-Stage3 |
4.943000E-01 |
| Normal-vs-Stage4 |
2.718000E-01 |
| Stage1-vs-Stage2 |
2.242500E-03 |
| Stage1-vs-Stage3 |
5.185200E-01 |
| Stage1-vs-Stage4 |
2.851400E-01 |
| Stage2-vs-Stage3 |
3.685700E-02 |
| Stage2-vs-Stage4 |
1.035800E-01 |
| Stage3-vs-Stage4 |
6.504400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.744200E-01 |
| Normal-vs-AfricanAmerican |
6.719200E-01 |
| Normal-vs-Asian |
8.386600E-01 |
| Caucasian-vs-AfricanAmerican |
8.104600E-01 |
| Caucasian-vs-Asian |
9.618200E-01 |
| AfricanAmerican-vs-Asian |
7.983400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.240000E-01 |
| Normal-vs-Female |
4.714000E-01 |
| Male-vs-Female |
8.368400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.382400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.432300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.468620E-01 |
| Normal-vs-Age(81-100Yrs) |
3.985200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.515100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.546400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.784000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.139830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.609150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.227000E-01 |
| Classical-VS-Follicular |
7.57929999872786E-08 |
| Classical-VS-Other |
6.264400E-01 |
| Classical-VS-Normal |
7.713400E-01 |
| Tall-VS-Follicular |
1.436150E-04 |
| Tall-VS-Other |
4.116000E-01 |
| Tall-VS-Normal |
3.060800E-01 |
| Follicular-VS-Other |
2.161600E-01 |
| Follicular-VS-Normal |
5.413600E-04 |
| Other-VS-Normal |
7.130000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.729500E-02 |
| Normal-vs-N1 |
7.421600E-01 |
| N0-vs-N1 |
3.678300E-02 |
|
|
